1. Staphylococcus aureus bacteremia in patients with hematological malignancies and/or agranulocytosis.
- Author
-
Espersen F, Frimodt-Møller N, Rosdahl VT, Jessen O, Faber V, and Rosendal K
- Subjects
- Aged, Endocarditis, Bacterial etiology, Female, Humans, Male, Polycythemia Vera microbiology, Sepsis immunology, Sepsis mortality, Staphylococcal Infections immunology, Staphylococcal Infections mortality, Waldenstrom Macroglobulinemia microbiology, Agranulocytosis microbiology, Leukemia microbiology, Lymphoma microbiology, Sepsis etiology, Staphylococcal Infections etiology
- Abstract
A total of 6,253 cases of Staphylococcus aureus bacteremia, including 274 (4.4%) endocarditis cases, were registered in Denmark in the period 1975-1984. Patients with hematological malignancies and/or agranulocytosis accounted for 479 of the bacteremia cases. The incidence of endocarditis in this group of patients was only 0.4% as compared to 4.7% in other patients with staphylococcal bacteremia (p less than 0.01). The lower incidence of endocarditis complicating bacteremia in these patients may justify a shorter course of therapy than usually recommended for suspected endocarditis. Patients with hematological malignancies and other patients with agranulocytosis had a higher mortality (49 and 46%, respectively) than other patients with S. aureus bacteremia (33%). The highest mortality was found in patients with multiple myeloma (71%, p less than 0.01), the lowest in patients with acute lymphocytic leukemia (28%, p less than 0.01). The higher mortality in these patients may indicate that empiric antibiotic regimens in granulocytopenic patients should include a specific anti-staphylococcal agent.
- Published
- 1987
- Full Text
- View/download PDF